Jason Hurst, MD
Adult Reconstructive Orthopaedic Surgery · New Albany, OHNPI 1760667810
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $247,106 of the $255,313 with a category attached, or 96.8%. Total Joint Orthopedics, Inc. accounts for 97.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $51,383 and has fallen 99.4% since, to $297 in 2025.
Across 72 payments — averaging $3546.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Total Joint Orthopedics, Inc.$248K
- Zimmer Biomet$7K
- Davol Inc.$122
- Pacira Pharmaceuticals Incorporated$44
- Pacira Therapeutics, Inc.$21
- Ferring Pharmaceuticals Inc.$19
- plus $51 from 3 others
Across 35 payments — averaging $801.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$28K
Across 7 payments — averaging $42,147 each. An ownership or investment interest held by the physician or an immediate family member.
- SPR Therapeutics, Inc$295K
What the payments were for
- Royalty or licence$247,10697%
- Consulting fees$2,0001%
- Travel & lodging$1,4431%
- Food & beverage$1,2470%
- Education$3,2801%
- Gifts$2370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Total Joint Orthopedics, Inc. | 34 | $248,334 |
| Zimmer Biomet | 29 | $6,722 |
| Davol Inc. | 3 | $122 |
| Pacira Pharmaceuticals Incorporated | 1 | $44 |
| Pacira Therapeutics, Inc. | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Si-bone, Inc. | 1 | $18 |
| Haemonetics Corporation | 1 | $17 |
| DJO, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oxford$3,718
- Juggerknot$866
- Juggerknot-Sports Medicine$848
- Juggerknotless Soft Anchor$421
- Juggerknotless$128
- Identity$123
How this compares
$255,313 in reported general payments places this provider in the 85th percentile of 59 adult reconstructive orthopaedic surgery providers in Ohio.
See all adult reconstructive orthopaedic surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 131 | $5,345 |
| Meloxicam | 487 | $2,215 |
| Prednisone | 119 | $138 |
| Oxycodone Hcl | 12 | $57 |
| Tramadol Hcl | 16 | $49 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in New Albany
- Adolph LombardiNew Albany$14.7M
- Keith BerendNew Albany$4.6M
- Michael MorrisNew Albany$252K
- Ray WasielewskiColumbus$9.6M
- Viktor KrebsCleveland$7.5M
- Nicolas PiuzziCleveland$1.2M
- Michael BloomfieldCleveland$321K
- Matthew BealColumbus$319K
- Trevor MurrayCleveland$192K
- James VoosCleveland$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.